National Health Commission (NHC) Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Henan Provincial Center for Disease Control and Prevention, Zhengzhou, China.
Microbiol Spectr. 2023 Jun 15;11(3):e0453722. doi: 10.1128/spectrum.04537-22. Epub 2023 Apr 11.
To understand the molecular evolution of human parainfluenza virus type 2 (HPIV2), 21 Hemagglutinin-Neuraminidase (HN) gene sequences covering seven Chinese provinces in 2011 and 2017 to 2021 were combined with 90 published HN sequences worldwide for phylogenetic analysis. The result showed that global HPIV2 could be classified into two distinct clusters (I and II), five lineages (IA to IIE), and four sublineages (IB1 and 2, and IIE1 and 2). The minimum genetic distances between different clusters and lineages were 0.049 and 0.014, respectively. In the last decade, one lineage (IID) and three sublineages (IB1, IB2, and IIE1) have been cocirculating in China, with the sublineages IB2 and IIE1 dominating, while sublineages IB1 and IIE1 are dominant globally. In addition, the spread of HPIV2 had relative spatial clustering, and sublineage IB2 has only been detected in China thus far. The overall evolution rate of HPIV2 was relatively low, on the order of 10 substitutions/site/year, except for sublineage IB2 at 10 substitutions/site/year. Furthermore, human-animal transmission was observed, suggesting that the HPIV2 might have jumped out of animal reservoirs in approximately 1922, the predicted time of a common ancestor. The entire HN protein was under purifying/negative selection, and the specific amino acid changes and two novel N-glycosylation sites (N316 and N517) in sublineages IB1, IB2, and IIE1 were mostly located in the globular head region of the HN protein. In this study, preliminary evolutionary characteristics of HPIV2 based on the HN gene were obtained, increasing the recognition of the evolution and adaptation of HPIV2. The phylogenetic analysis showed that global HPIV2 could be classified into two distinct clusters (I and II) and five lineages (IA to IIE) with at least 0.049 and 0.014 genetic distances between clusters and lineages, respectively. Furthermore, lineages IB and IIE could be further divided into two sublineages (IB1-2 and IIE1-2). All China sequences belong to one lineage and three sublineages (IB1, IB2, IID, and IIE1), among which sublineages IB2 and IIE1 are predominant and cocirculating in China, while sublineages IB1 and IIE1 are dominant globally. The overall evolution rate of HPIV2 is on the order of 10 substitutions/site/year, with the highest rate of 2.18 × 10 for sublineage IB2. The entire HN protein is under purifying/negative selection, and the specific amino acid substitutions and two novel N-glycosylation sites (N316 and N517) in sublineages IB1, IB2, and IIE1 are mostly located in the globular head region of the HN protein.
为了了解人类副流感病毒 2 型(HPIV2)的分子进化,我们结合了全球 90 个发表的 HN 序列,对 2011 年至 2017 年至 2021 年中国七个省份的 21 个血凝素神经氨酸酶(HN)基因序列进行了系统进化分析。结果表明,全球 HPIV2 可分为两个明显的簇(I 和 II)、五个谱系(IA 至 IIE)和四个亚谱系(IB1 和 2 以及 IIE1 和 2)。不同簇和谱系之间的最小遗传距离分别为 0.049 和 0.014。在过去的十年中,一个谱系(IID)和三个亚谱系(IB1、IB2 和 IIE1)一直在中国共同传播,亚谱系 IB2 和 IIE1 占主导地位,而亚谱系 IB1 和 IIE1 在全球占主导地位。此外,HPIV2 的传播具有相对的空间聚类,亚谱系 IB2 迄今为止仅在中国检测到。HPIV2 的整体进化速度相对较低,约为每年 10 个替换/位点,亚谱系 IB2 除外,其进化速度为每年 10 个替换/位点。此外,还观察到了人-动物传播,表明 HPIV2 可能在大约 1922 年从动物储库中跳了出来,这是共同祖先的预测时间。整个 HN 蛋白处于净化/负选择之下,亚谱系 IB1、IB2 和 IIE1 中的特定氨基酸变化和两个新的 N-糖基化位点(N316 和 N517)主要位于 HN 蛋白的球形头部区域。本研究基于 HN 基因获得了 HPIV2 的初步进化特征,增加了对 HPIV2 进化和适应的认识。系统进化分析表明,全球 HPIV2 可分为两个明显的簇(I 和 II)和五个谱系(IA 至 IIE),簇与谱系之间的遗传距离至少为 0.049 和 0.014。此外,谱系 IB 和 IIE 可进一步分为两个亚谱系(IB1-2 和 IIE1-2)。所有中国序列都属于一个谱系和三个亚谱系(IB1、IB2、IID 和 IIE1),其中亚谱系 IB2 和 IIE1 在中国占主导地位且共同传播,而亚谱系 IB1 和 IIE1 则在全球占主导地位。HPIV2 的整体进化速度约为每年 10 个替换/位点,亚谱系 IB2 的最高速度为每年 2.18×10。整个 HN 蛋白处于净化/负选择之下,亚谱系 IB1、IB2 和 IIE1 中的特定氨基酸取代和两个新的 N-糖基化位点(N316 和 N517)主要位于 HN 蛋白的球形头部区域。